ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

TAYMOUR MALAK M.D.

2800 N CALIFORNIA ST STE 11 2800 N. CALIFORNIA STREET SUITE 11

Stockton | California | 95204

(209) 465-5891

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,865Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 6969

$1.56M Total Retail Price of All Prescriptions

Rank: 61 out of 6969

1,295 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 1,295 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 25,569 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 1,557 1,131 1 6
SIMVASTATIN 1,326 1,002 2 1
HYDROCODONE-ACETAMINOPHEN 1,256 816 S3 3 3
METFORMIN HCL 1,234 871 4 7
LEVOTHYROXINE SODIUM 1,125 890 5 5
LISINOPRIL 1,106 806 6 2
LOSARTAN POTASSIUM 970 818 7 12
AMLODIPINE BESYLATE 916 689 8 4
FUROSEMIDE 903 755 9 10
LOVASTATIN 894 777 10 15
HYDROCHLOROTHIAZIDE 718 540 11 8
GLIMEPIRIDE 618 515 12 44
GABAPENTIN 557 367 13 17
METOPROLOL SUCCINATE 555 452 14 22
ATENOLOL 442 343 15 9
ZOLPIDEM TARTRATE 424 293 16 16
METOPROLOL TARTRATE 416 345 17 13
ALENDRONATE SODIUM 385 311 18 14
TAMSULOSIN HCL 348 330 19 23
PANTOPRAZOLE SODIUM 333 245 20 31
SERTRALINE HCL 313 258 21 38
IBUPROFEN 302 196 22 29
GLIPIZIDE 294 248 23 21
POTASSIUM CHLORIDE 291 232 24 30
JANUVIA 291 214 24 41
NAPROXEN 287 205 26 62
WARFARIN SODIUM 286 274 27 20
CLOPIDOGREL 263 201 28 48
TRAMADOL HCL 263 184 28 27
ATORVASTATIN CALCIUM 261 187 30 11
FLUTICASONE PROPIONATE 251 150 31 24
CARVEDILOL 248 234 32 25
AZITHROMYCIN 236 172 33 42
TRIAMCINOLONE ACETONIDE 233 190 34 55
FLUOXETINE HCL 230 157 35 43
ADVAIR DISKUS 221 146 36 45
PROAIR HFA 219 136 37 33
DIOVAN 218 202 38 26
NEXIUM 200 147 39 52
ALLOPURINOL 200 188 39 35
SPIRIVA 197 161 41 66
GLYBURIDE 189 142 R 42 54
PLAVIX 182 144 43 68
LANTUS 171 125 44 50
PRAVASTATIN SODIUM 160 147 45 19
DONEPEZIL HCL 157 127 46 32
LOSARTAN-HYDROCHLOROTHIAZIDE 155 140 47 53
RANITIDINE HCL 151 111 48 46
NAMENDA 150 137 49 51
BENAZEPRIL HCL 150 136 49 18
VENTOLIN HFA 145 109 51 125
CRESTOR 145 102 51 39
BENICAR 140 137 53 107
MELOXICAM 140 138 53 36
FAMOTIDINE 134 119 55 37
PAROXETINE HCL 129 82 56 65
CIPROFLOXACIN HCL 129 94 56 64
ZETIA 128 88 58 98
PREMARIN 123 76 R 59 156
DIVALPROEX SODIUM 119 92 60 103
ROPINIROLE HCL 118 91 61 162
PREDNISONE 118 104 61 70
KLOR-CON 8 118 102 61 104
BACLOFEN 116 51 64 86
DEXILANT 114 87 65 110
AMITRIPTYLINE HCL 109 85 R 66 87
FINASTERIDE 109 104 66 80
SYMBICORT 108 97 68 149
ISOSORBIDE MONONITRATE ER 107 79 69 81
OXYBUTYNIN CHLORIDE 106 75 70 126
PHENYTOIN SODIUM EXTENDED 105 48 71 169
DIOVAN HCT 101 45 72 57
DICYCLOMINE HCL 101 52 72 317
DIPHENOXYLATE-ATROPINE 94 59 74 214
MIRTAZAPINE 93 81 75 76
DILTIAZEM 24HR ER 93 74 75 183
VYTORIN 89 77 77 148
SINGULAIR 89 48 77 84
CITALOPRAM HBR 88 50 79 34
ONGLYZA 87 75 80 164
LIPITOR 87 38 80 89
DOXAZOSIN MESYLATE 85 60 82 74
GEMFIBROZIL 84 63 83 85
ENALAPRIL MALEATE 82 62 84 56
DICLOFENAC SODIUM 82 54 84 78
CAPTOPRIL 82 82 84 226
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 51 87 114
ACETAMINOPHEN-CODEINE 79 65 S3 88 73
LANTUS SOLOSTAR 79 49 88 154
ESCITALOPRAM OXALATE 79 49 88 93
ACTOS 78 41 91 61
SURE COMFORT 76 59 92 263
BUPROPION HCL SR 75 68 93 195
FENOFIBRATE 75 57 93 63
CEPHALEXIN 75 51 93 96
OXYBUTYNIN CHLORIDE ER 74 70 96 165
PEN NEEDLE 74 60 96 196
ISOSORBIDE DINITRATE 74 62 96 231
CARBAMAZEPINE 73 51 99 204
NOVOLOG 73 64 99 166
LYRICA 71 57 101 137
BUPROPION HCL 70 57 102 391
COMBIVENT 70 57 102 170
ACIPHEX 68 60 104 181
SPIRONOLACTONE 67 44 105 102
CLONIDINE HCL 67 41 105 59
DIGOXIN 65 60 107 71
TRAZODONE HCL 65 33 107 47
CARBIDOPA-LEVODOPA 65 65 107 119
LANSOPRAZOLE 64 39 110 171
CARISOPRODOL 62 40 R 111 69
MEGESTROL ACETATE 62 53 R 111 129
AMOXICILLIN 59 45 113 99
LEXAPRO 58 23 114 200
TRICOR 58 30 114 143
KLOR-CON M20 57 57 116 201
FLUOCINONIDE 56 32 117 134
PRIMIDONE 55 50 118 398
QVAR 54 36 119 120
HYDROXYZINE HCL 54 46 R 119 159
AMLODIPINE BESYLATE-BENAZEPRIL 53 28 121 91
HUMALOG 52 27 122 167
VESICARE 51 33 123 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.